Ankylosing spondylitis refers to the inflammatory disorder associated with fibrous or bony bridging of joints in the spine, including the bridging of intervertebral discs. Objective: To assess the Infliximab Infusion and its Relation on Disease Activity, Severity and Acute Phase Reactant Protein in Iraqi Patients with Ankylosing Spondylitis. Patients and Method: Sixty (60) patients were included in this study, were diagnosed as established AS patients who were attending the rheumatology outpatient clinic of Baghdad teaching hospital, thirty (30) patients of them were on conventional treatment (steroid and/or cytotoxic drugs), while the other thirty (30) patients were on biological treatment (infliximab infusion). Mean serum level of matrix metalloproteinase-3 was statistically higher in patient group (4.42 ± 3.05 ng/ml) than control group (2.69 ± 2.57 ng/ml), and also was statistically higher in patients on conventional treatment (5.31 ± 3.16 ng/ml) than those on biological treatment (3.54 ± 2.70 ng/ml). The study shown that matrix metalloproteinase-3 was higher in patient group than control group and also was higher in patients on conventional treatment than in patients on biological treatment

A prospective study was performed on 150 healthy term newborn babies who had been examined in postnatal ward of gynecology and obstetrics department at Al-Mahmodyia general hospital during the period from of April to December 2019. Among the total 150 surveyed cases, 71 cases were males (47%), 79 cases were females (53%). The mean time of umbilical cord separation for the male cases was 8.5 days, whereas that of the female cases was 8.3 days. In the studied newborns, the mean time of umbilical cord separation was 8.4 days, shortest documented time of separation was 4 days (3 cases) while the longest time of separation was 14 days (one case only). Most of the cases; 71 (47.33%) cases had separated the umbilical cord in the time period (>8 to 11 days), whereas the least group separated the UC in the time period (>11 days).